Status:
RECRUITING
Clinical and Biomolecular Assessment for the Monitoring of Patients Undergoing Regenerative Medicine Treatments with Orthobiologics
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Musculoskeletal System Disease
Eligibility:
All Genders
6+ years
Brief Summary
the aim is to improve the evaluation of the outcomes of regenerative medicine treatments performed in the regenerative medicine centers involved in the study. patients who undergo regenerative medici...
Eligibility Criteria
Inclusion
- patients who received indication for regerative medicine treatment for one of the following pathologies: Knee or hip or ankle osteoarthritis, patellar or Achilles tendon pain, shouder or elbow pain;
- males and females;
- age \>= 6 years.
Exclusion
- age \< 6 years
- patients not compliant with post-treatment monitoring procedures
- pregnancy
Key Trial Info
Start Date :
May 30 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2030
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04711551
Start Date
May 30 2018
End Date
May 30 2030
Last Update
February 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Clinico San Siro (satellite center)
Milan, Italia, Italy, 20100
2
IRCCS Ospedale Galeazzi-Sant'Ambrogio (coordinator)
Milan, Italy, Italy, 20157